Home
NewsNewsSmart IUD to track uterus in real-time is being worked upon by Verso Biosense, which will help with data that has in the past been pretty hard to get, offering continuous intrauterine insights for better reproductive care.
Verso Biosense, which is based out of Oxfordshire, is working on an intrauterine device - IUD to track the uterus in real-time that can measure important physiological conditions like temperature and oxygen levels consistently for several days. The company says the technology could help scientists learn more about one of the least known organs in the human body by giving them data that has been difficult to get in the past.
The smart IUD to track the uterus in real-time looks like a regular IUD, but it has tiny sensors inside that collect data all the time and send it wirelessly for evaluation. The device is being looked into as a way to monitor uterine conditions in women who have had unsuccessful IVF cycles in order to find the circumstances that give embryos the best chance of a successful implantation.
Kate Rowley, the CEO of Verso Biosense, said, “Medicine has made extraordinary advances in many fields, but the uterus is still something of a black box. Our goal is to shine a light inside the uterine environment and gather the data needed to truly understand how it functions. Once we can see what’s happening in real time, we can start developing far more personalized and effective treatments.”
There are studies in science demonstrating that elements like temperature and oxygen levels can affect how embryos grow, but it has been very difficult to measure such factors directly inside the uterus. Verso Biosense wants to create large-scale datasets over time that show patterns across menstrual cycles. This kind of long-term data is not there as of now.
As per Rowley, “To really understand reproductive health, we need longitudinal data – potentially monitoring biomarkers over months or years. That’s a huge engineering challenge when the device itself is extremely small.”
In the years to come, intrauterine monitoring could be used for more than just fertility research. It could also be used to study endometriosis, PCOS, uterine cancers, perimenopause, and menopause. This would add a new layer of data to conditions that are still not well-defined because there is no direct physiological measurement.
IVF Academy USA launched its new OBGYN Clinic-Ready Fertility Services Accelerator Program to help board-certified OBGYNs confidently add comprehensive fertility services in their existing practices.
IVF bills can hit $30,000, creating major financial barriers for families. The HOPE with Fertility Services Act aims to mandate insurance coverage for infertility diagnosis, treatment, and preservation, potentially benefiting 133 million Americans while addressing affordability and expanding access to essential reproductive healthcare services across the United States.
ASEAN's First Telemedicine IVF by Inspire IVF introduces a new era of remote fertility care. Combining AI technology with expert consultation, the platform enables global access, real-time monitoring, and personalised treatment planning, positioning Thailand as a leading hub for fertility services and advancing digital transformation in reproductive healthcare.
A new Alabama bill seeks to protect access to IVF and contraceptives in Huntsville and statewide. Proposed by Rep. Marilyn Lands, the legislation aims to safeguard reproductive healthcare, prevent restrictions on federally approved treatments, and support both patients and providers amid ongoing legal and policy debates surrounding fertility and contraception access.
Kindbody and Future Family partner to expand access to fertility care through flexible financing and personalised clinical support. Offering up to $50,000 in funding, concierge guidance, and inclusive services, the collaboration helps reduce financial barriers, enabling more individuals and families to pursue IVF and other reproductive treatments with confidence.
A wearable biosensor for IVF treatments developed by Symex Labs in partnership with the University of Melbourne and Monash IVF enables real-time hormone monitoring through a skin patch. By reducing reliance on invasive blood tests, the innovation improves patient comfort, enhances treatment precision, and expands access to fertility care, particularly for patients in remote and underserved regions.
